This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
To allocate COVID-19vaccines, the CDC’s Advisory Committee on Immunization Practices , the National Academies of Sciences, Engineering and Medicine (NASEM), and the World Health Organization (WHO) identified ethical goals for prioritization, such as maximizing benefit and minimizing harm, mitigating health inequities, and reciprocity.
Alicia Ely Yamin is a Lecturer on Law and the Senior Fellow on Global Health and Rights at the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School; and a Senior Advisor on Human Rights and Health Policy at Partners In Health.
Transparency and education are essential to building trust in vaccines, Edelman concludes in this study, noting that 64% of U.S. health citizens say they will need to understand the science and development process used to create a COVID-19vaccine before they will fully trust that it is safe.
Judge Zione Ntaba’s contribution highlights how courts in Malawi decided cases relating to the Government’s responses to the COVID-19 pandemic , including, in particular, the provision of social security measures in parallel with lockdown measures, and the policy proposals relating to mandatory COVID-19vaccinations.
This week marks the two-year anniversary of World Health Organization Director-General Tedros Adhanom declaring COVID-19 a pandemic. By Chloe Reichel, Marissa Mery, and Michael Ashley Stein.
Over the summer of 2021, concern grew that the vaccines were not providing the near-perfect protection against symptomatic disease and transmission that had first emboldened the administration to jettison other public health measures. ” which was originally published on January 5, 2022 on Medium. Read the first and second parts here.
Despite having an outsized role in the discovery, development, manufacturing, and procurement of COVID-19vaccines, therapeutics, and diagnostics, the federal government has generally not exercised any leverage in ensuring fair pricing and affordable access to these essential medical products.
ASPE analyzed data from 62,451,150 people who had 1 or more vaccine doses administered by 3-10-21. who had received 1 or more doses of COVID-19vaccines by race/ethnicity were: 66% of White, non-Hispanic people (60% of U.S. of Hispanic and LatinX people (19% of U.S. The percentages of people in the U.S.
Health Populi’s Hot Points: By June 2020, it became clear to the Centers for Disease Control that COVID-19 had been exacting a tougher toll on the lives of people of color in the U.S. than on white people.
to classify liver transplantation as “established” instead of experimental, thus clearing the way for insurance coverage; and (4) increased administrative agency and media outreach, as occurred during the COVID-19vaccination campaign (although this certainly has not led to consensus on vaccination in the United States).
By Nate Holdren. Every day in the pandemic, many people’s lives end, and others are made irrevocably worse. [1]. These daily losses matter inestimably at a human level, yet they do not matter in any meaningful way at all to the public and private institutions that govern our lives.
Last spring, the United States crossed the bleak and preventable 1,000,000-death mark for lives lost during the COVID-19 pandemic. By Chloe Reichel and Benjamin A. In this symposium, our hope is to acknowledge — and mourn — this current era of mass suffering and death.
Over the course of the pandemic it has been popular to claim that we have “learned lessons from COVID,” as though this plague has spurred a revolution in how we treat illness, debility, and death under capitalism. By Beatrice Adler-Bolton and Artie Vierkant.
By Nate Holdren Last week, David Leonhardt took to the pages of the New York Times to celebrate the latest COVID death figures , which he claims mean the U.S. is no longer in a pandemic, because there are no more “excess deaths.” The hunger for good news is, of course, understandable amid this ongoing nightmare.
can stop wearing masks, has attempted to change the reality of our COVID risk landscape by assigning new colors to risk levels and massively shifting the parameters of these criteria. By Chloe Reichel. What is more important: your comfort, or a person’s life? These are the stakes of the move to unmask in the U.S. .
By Sam Friedman Amid an emergent international consensus that the COVID pandemic is “over,” writings about the pandemic and its meanings have burst forth like the flowers of June. This article will focus on one such book, Lessons from the COVID War: An Investigative Report.
By Nate Holdren. The present pandemic nightmare is the most recent and an especially acute manifestation of capitalist society’s tendency to kill many, regularly, a tendency that Friedrich Engels called “social murder.” Capitalism kills because destructive behaviors are, to an important extent, compulsory in this kind of society.
2: Moderna, funded with nearly $1 billion in taxpayer dollars to develop a COVID-19vaccine, sets the highest prevailing market price for the product. The controversy here is that this was the highest price set although the company received 100% of the development costs for the vaccine covered by the U.S. government.
Edelman then connects the dots between information hygiene and vaccine hesitancy in this chart. It’s clear that health citizens with lower information hygiene have lower willingness to get a COVID-19vaccination in the next year compared with consumers embodying higher information hygiene, vetting data sources and engaging with news.
Interestingly, these are two of the most prominent life science companies that have been part of Operation Warp Speed to accelerate the development of COVID-19vaccines. Among the top 20 in this study were two pharma brands — Pfizer and AstraZeneca.
No other country has recorded as many total COVID-19 casualties as the United States — indeed, no other country comes close. By Martha Lincoln. From spring 2020 through the present day, Americans have endured levels of sickness and death that are outliers among not only wealthy democracies, but around the world.
This series, which will run in four parts, has been adapted from “ A year in, how has Biden done on pandemic response? ” which was originally published on January 5, 2022 on Medium. Read the first , second , and third parts here. By Justin Feldman. for the first time.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content